JEFFERSON CITY (AP) — Missouri’s attorney general says the state will receive $1.5 million as part of a settlement by a pharmaceutical company with more than three dozen states.
AstraZeneca was accused of marketing its psychiatric drug Seroquel for unapproved uses, including treatment of insomnia and Alzheimer’s disease. The drug is approved to treat schizophrenia, bipolar disorder and depression.
AstraZeneca has denied the allegation but says it agreed to the $68.5 million settlement with 37 states to move forward with its business.
Missouri Attorney General Chris Koster says the settlement ends a three-year investigation. He says the monetary settlement will make other pharmaceutical companies think twice about promoting drugs for unapproved uses.
Copyright Associated Press